Results 31 to 40 of about 4,504 (202)
Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases. [PDF]
Denosumab has been used successfully to treat disease-associated osteoclast overactivity, including giant cell tumor of bone. Given its mechanism of action, denosumab is a potent potential treatment of other osteoclast bone dysplasias including central ...
Bernthal, Nicholas M +8 more
core +2 more sources
Fibrous dysplasia: A tale of two syndromes
Fibrous dysplasia (FD) is a rare, non-inherited, congenital bone disorder which may be monostotic or polyostotic. The polyostotic form may rarely present in syndromic forms when associated with extra-skeletal manifestations.
Jacques Fourie +3 more
doaj +1 more source
Evolução da displasia fibrosa óssea na síndrome de McCune Albright [PDF]
McCune Albright syndrome is a rare disorder characterized by polyostotic fibrous dysplasia, café-au-lait spots and some endocrine hyperfunction, mostly precocious puberty.
Dias-da-Silva, Magnus Régios [UNIFESP] +3 more
core +2 more sources
Background: McCune Albright syndrome (MAS) is a rare heterogeneous clinical syndrome without any predilection for ethnic group. Classic form includes triad of fibrous dysplasia, café au late spots and autonomous hyper function of one or more endocrine ...
Ali Reza Navabazam +3 more
doaj
Management of infertility in a patient presenting with ovarian dysfunction and McCune-Albright syndrome [PDF]
Persistent autonomous ovarian dysfunction in McCune-Albright syndrome (MAS) patients is associated with the development of multiple dominant follicles, premature luteinization, cyst formation, and anovulatory infertility.
Fauser, B.C.J.M. (Bart) +3 more
core +3 more sources
Atypical presentation of craniofacial fibrous dysplasia in an adult
Fibrous dysplasia is a sporadic fibroosseous anomaly affecting the skeletal system. Craniofacial synostosis is one of its subtypes with ocular complications.
Padma B Prabhu +2 more
doaj +1 more source
IntroductionFibrous dysplasia is a benign fibrous bone tumor that accounts for 5% to 10% of benign bone tumors. It can manifest as simple fibrous dysplasia (70%–80%), polyostotic fibrous dysplasia (20%–30%), with approximately the same incidence in men ...
Qifan Yang +4 more
doaj +1 more source
Characterization of an FTLD-PDB family with the coexistence of SQSTM1 mutation and hexanucleotide (G4C2) repeat expansion in C9orf72 gene [PDF]
The C9orf72 expansion is considered a major genetic cause of familial frontotemporal dementia (FTD) in several patients' cohorts. Interestingly, C9orf72 expansion carriers, present also abundant neuronal p62-positive inclusions.
Almeida, MR +8 more
core +1 more source
Clinicopathologic Analysis of Sarcomas in the Oral and Maxillofacial Region: A Systematic Review
ABSTRACT Objective This study aimed to systematically review primary sarcomas in the oral and maxillofacial region, focusing on patient demographics and sarcoma‐specific characteristics, including clinical presentation, histopathology, treatment approaches, outcomes, and survival rates.
Iara Vieira Ferreira +7 more
wiley +1 more source
Fibrous dysplasia of maxilla: Report of two cases
Fibrous dysplasia (FD) is an idiopathic skeletal disorder in which the trabecular bone is replaced and distorted by poorly organized, structurally unsound fibro-osseous tissue. The lesion is classified into two forms: Monostotic (75-80%) and polyostotic.
Nisha Dua +3 more
doaj +1 more source

